Longaeva Partners’s EyePoint Inc EYPT Stock Holding History

Longaeva Partners’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$548K	–	221
2025 Q4	$548K	Buy	+30,000	New	+$425K	0.05%	110

Other funds holding EYPT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Longaeva Partners's EYPT Position: Q1 2026 in Review

Longaeva Partners sold out of EyePoint Inc (EYPT) in Q1 2026, closing a stake of 30,000 shares — an estimated $548K sold.

Longaeva Partners first reported a position in EYPT in Q4 2025 and held it in 1 quarter. The position peaked at $548K in Q4 2025. 189 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

Longaeva Partners reported no remaining EyePoint Inc position as of Q1 2026 after selling out during the quarter.
Longaeva Partners sold 30,000 EyePoint Inc shares in Q1 2026, an estimated $548K.
Longaeva Partners first reported a position in EyePoint Inc in Q4 2025 and held it in 1 quarter.
Longaeva Partners's EyePoint Inc position peaked at $548K in Q4 2025.
189 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.